Observational study on the use of Neem and Hypericum oils in non-hospitalized COVID-19 patients

This report describes the efforts of a healthcare worker in the Campania region badly affected by COVID-19 to repurpose a pre-existing medical device with the intent to benefit patients and ease pressure on local hospitals. Materials and Methods: The study consist of self-reported symptoms, collecte...

Full description

Bibliographic Details
Main Authors: Carnevali, Fiorella, Noschese, Giuseppe
Format: Report
Language:unknown
Published: Zenodo 2020
Subjects:
Online Access:https://dx.doi.org/10.5281/zenodo.4376587
https://zenodo.org/record/4376587
_version_ 1821558417921146880
author Carnevali, Fiorella
Noschese, Giuseppe
author_facet Carnevali, Fiorella
Noschese, Giuseppe
author_sort Carnevali, Fiorella
collection DataCite
description This report describes the efforts of a healthcare worker in the Campania region badly affected by COVID-19 to repurpose a pre-existing medical device with the intent to benefit patients and ease pressure on local hospitals. Materials and Methods: The study consist of self-reported symptoms, collected over a two month period on an unscreened cohort of patients in a wide age range presenting mild to moderate symptoms consistent with COVID-19, treated with a spray containing Neem and Hypericum (1 Primary Wound Dressing, Kerecis, Iceland) with directions for oral and nasal self-administration for two weeks. The severity and nature of the symptoms were captured on a scale of 0 (not present) to 3 (serious). After beginning treatment, the patients were followed up by phone call or visits and their self-reported symptoms were documented in the form of a score. Results: Out of the 64 treated patients, 63 had recovered eventually as of May 2020 and none of them had received hospital care or died, only 29 patients gave consent for their data to be presented here. Due to limited resources, only 4 out of these 29 patients were screened for SARS-CoV-2 and all tested positive. All have recovered fully, except for one 25-year-old female who still has a low-grade fever after 2 months of illness. No side effects or discomfort were reported from using the spray. Patients who started treatment early after the onset of symptoms had a much shorter course of the disease than those who started treatment later: the average time to recovery was 17.9 ± 9.8 days (range 5-38 days). Discussion: The spray described here contains 50% neem oil and 50% Hypericum (St. John´s Wort). The antiviral properties of these two spray constituents have been previously reported, including against another related Corona virus, the Infectious bronchitis virus (IBV). Direct comparison to the recovery trajectory of other Neapolitan COVID-19 patients is impossible as most mildly symptomatic patients were never screened. However, due to the nature of the outbreak in the city, it can be assumed that the majority of the patients were indeed SARS-Cov-2 positive. In light of the statistics published for the Italian outbreak, it is encouraging that all except one of the larger 64 patient cohort have at the time of this report recovered without hospitalization.
format Report
genre Iceland
genre_facet Iceland
id ftdatacite:10.5281/zenodo.4376587
institution Open Polar
language unknown
op_collection_id ftdatacite
op_doi https://doi.org/10.5281/zenodo.4376587
https://doi.org/10.5281/zenodo.4376588
op_relation https://dx.doi.org/10.5281/zenodo.4376588
op_rights Open Access
Creative Commons Attribution 4.0 International
https://creativecommons.org/licenses/by/4.0/legalcode
cc-by-4.0
info:eu-repo/semantics/openAccess
op_rightsnorm CC-BY
publishDate 2020
publisher Zenodo
record_format openpolar
spelling ftdatacite:10.5281/zenodo.4376587 2025-01-16T22:41:30+00:00 Observational study on the use of Neem and Hypericum oils in non-hospitalized COVID-19 patients Carnevali, Fiorella Noschese, Giuseppe 2020 https://dx.doi.org/10.5281/zenodo.4376587 https://zenodo.org/record/4376587 unknown Zenodo https://dx.doi.org/10.5281/zenodo.4376588 Open Access Creative Commons Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/legalcode cc-by-4.0 info:eu-repo/semantics/openAccess CC-BY Neem oil, St. John's Wort oil, Hypericum perforatum, Azadirachta indica, COVID-19, SARS-CoV-2 Preprint Text article-journal ScholarlyArticle 2020 ftdatacite https://doi.org/10.5281/zenodo.4376587 https://doi.org/10.5281/zenodo.4376588 2021-11-05T12:55:41Z This report describes the efforts of a healthcare worker in the Campania region badly affected by COVID-19 to repurpose a pre-existing medical device with the intent to benefit patients and ease pressure on local hospitals. Materials and Methods: The study consist of self-reported symptoms, collected over a two month period on an unscreened cohort of patients in a wide age range presenting mild to moderate symptoms consistent with COVID-19, treated with a spray containing Neem and Hypericum (1 Primary Wound Dressing, Kerecis, Iceland) with directions for oral and nasal self-administration for two weeks. The severity and nature of the symptoms were captured on a scale of 0 (not present) to 3 (serious). After beginning treatment, the patients were followed up by phone call or visits and their self-reported symptoms were documented in the form of a score. Results: Out of the 64 treated patients, 63 had recovered eventually as of May 2020 and none of them had received hospital care or died, only 29 patients gave consent for their data to be presented here. Due to limited resources, only 4 out of these 29 patients were screened for SARS-CoV-2 and all tested positive. All have recovered fully, except for one 25-year-old female who still has a low-grade fever after 2 months of illness. No side effects or discomfort were reported from using the spray. Patients who started treatment early after the onset of symptoms had a much shorter course of the disease than those who started treatment later: the average time to recovery was 17.9 ± 9.8 days (range 5-38 days). Discussion: The spray described here contains 50% neem oil and 50% Hypericum (St. John´s Wort). The antiviral properties of these two spray constituents have been previously reported, including against another related Corona virus, the Infectious bronchitis virus (IBV). Direct comparison to the recovery trajectory of other Neapolitan COVID-19 patients is impossible as most mildly symptomatic patients were never screened. However, due to the nature of the outbreak in the city, it can be assumed that the majority of the patients were indeed SARS-Cov-2 positive. In light of the statistics published for the Italian outbreak, it is encouraging that all except one of the larger 64 patient cohort have at the time of this report recovered without hospitalization. Report Iceland DataCite
spellingShingle Neem oil, St. John's Wort oil, Hypericum perforatum, Azadirachta indica, COVID-19, SARS-CoV-2
Carnevali, Fiorella
Noschese, Giuseppe
Observational study on the use of Neem and Hypericum oils in non-hospitalized COVID-19 patients
title Observational study on the use of Neem and Hypericum oils in non-hospitalized COVID-19 patients
title_full Observational study on the use of Neem and Hypericum oils in non-hospitalized COVID-19 patients
title_fullStr Observational study on the use of Neem and Hypericum oils in non-hospitalized COVID-19 patients
title_full_unstemmed Observational study on the use of Neem and Hypericum oils in non-hospitalized COVID-19 patients
title_short Observational study on the use of Neem and Hypericum oils in non-hospitalized COVID-19 patients
title_sort observational study on the use of neem and hypericum oils in non-hospitalized covid-19 patients
topic Neem oil, St. John's Wort oil, Hypericum perforatum, Azadirachta indica, COVID-19, SARS-CoV-2
topic_facet Neem oil, St. John's Wort oil, Hypericum perforatum, Azadirachta indica, COVID-19, SARS-CoV-2
url https://dx.doi.org/10.5281/zenodo.4376587
https://zenodo.org/record/4376587